Created at Source Raw Value Validated value
June 27, 2024, 4 p.m. usa

inclusion criteria: common criteria: * subjects with the ability to take the study product orally * ability to understand the study, the information about the symptoms and to comply with the treatment shots. * subject or legal guardian / representative willing to give informed consent in writing. influenza vaccine groups: * subjects who require hospitalization or external follow-up (outpatients or pades) * subjects over 60 years old who will receive the influenza vaccine covid-19 vaccine groups * subjects from long-stay centres attached to the hospital mare de déu de la mercè, and meet the following inclusion criteria: * groups: * subjects over 18 years of age who receive the covid-19 vaccine, in a stable clinical situation, at the discretion of the researcher, or * healthcare workers of the study centers, over 18 years of age who receive the covid-19 vaccine * availability to attend clinical visits.

inclusion criteria: common criteria: * subjects with the ability to take the study product orally * ability to understand the study, the information about the symptoms and to comply with the treatment shots. * subject or legal guardian / representative willing to give informed consent in writing. influenza vaccine groups: * subjects who require hospitalization or external follow-up (outpatients or pades) * subjects over 60 years old who will receive the influenza vaccine covid-19 vaccine groups * subjects from long-stay centres attached to the hospital mare de déu de la mercè, and meet the following inclusion criteria: * groups: * subjects over 18 years of age who receive the covid-19 vaccine, in a stable clinical situation, at the discretion of the researcher, or * healthcare workers of the study centers, over 18 years of age who receive the covid-19 vaccine * availability to attend clinical visits.

March 17, 2021, 12:31 a.m. usa

inclusion criteria: common criteria: - subjects with the ability to take the study product orally - ability to understand the study, the information about the symptoms and to comply with the treatment shots. - subject or legal guardian / representative willing to give informed consent in writing. influenza vaccine groups: - subjects who require hospitalization or external follow-up (outpatients or pades) - subjects over 60 years old who will receive the influenza vaccine covid-19 vaccine groups - subjects from long-stay centres attached to the hospital mare de déu de la mercè, and meet the following inclusion criteria: - groups: - subjects over 18 years of age who receive the covid-19 vaccine, in a stable clinical situation, at the discretion of the researcher, or - healthcare workers of the study centers, over 18 years of age who receive the covid-19 vaccine - availability to attend clinical visits.

inclusion criteria: common criteria: - subjects with the ability to take the study product orally - ability to understand the study, the information about the symptoms and to comply with the treatment shots. - subject or legal guardian / representative willing to give informed consent in writing. influenza vaccine groups: - subjects who require hospitalization or external follow-up (outpatients or pades) - subjects over 60 years old who will receive the influenza vaccine covid-19 vaccine groups - subjects from long-stay centres attached to the hospital mare de déu de la mercè, and meet the following inclusion criteria: - groups: - subjects over 18 years of age who receive the covid-19 vaccine, in a stable clinical situation, at the discretion of the researcher, or - healthcare workers of the study centers, over 18 years of age who receive the covid-19 vaccine - availability to attend clinical visits.